Today, Health Outcomes and Healthcare Management Research require more statistical input in order to satisfy NICE guidelines, and often these statistical requirements differ from the standard statistics required for pharmaceutical clinical trials. Quanticate offers a specialist statistical service for our Health Outcomes and Healthcare Management customers.
Over the past five years, our statistics department has developed specific expertise by working extensively on many aspects of Health Outcome studies.
Quanticate has developed specific analysis tools such as bootstrap algorithms to provide clients with accurate analysis of resource and cost data both quickly and cost-effectively. As well as writing analysis plans, conducting and reporting the analyses, our work has included power calculations for prospective studies and input into clinical protocols for additional Health Outcome endpoints.
In addition, we can advise on and conduct meta-analyses
of retrospective data. Our team of medical writers can search for relevant studies, grade them according to quality and write systematic reviews, while our statisticians can provide you with accurate estimates of treatment effectiveness, gathered from many diverse clinical trials.
- Health Related Quality of Life (HRQL)
- Clinical outcomes
- Resource utilisation
- Resource cost
- Estimation of QALY and Incremental
- Cost Effectiveness Ratios (ICERs)
In order to comply with the latest NICE guidelines, Quanticate can advise and conduct Probabilistic Sensitivity Analyses (PSA) to quantify the uncertainty of both your clinical and cost-effectiveness information in your NICE submissions.